Vigil Neuroscience, Inc.: Vigil Neuroscience Announces Update on its Small Molecule TREM2 Agonist Program

Press/Media

Period	8 Sep 2023

Media coverage

Title	Vigil Neuroscience, Inc.: Vigil Neuroscience Announces Update on its Small Molecule TREM2 Agonist Program
Media name/outlet	FinanzNachrichten.de
Country/Territory	Germany
Date	8/09/23
URL	https://www.finanznachrichten.de/nachrichten-2023-09/60068098-vigil-neuroscience-inc-vigil-neuroscience-announces-update-on-its-small-molecule-trem2-agonist-program-399.htm
Persons	Samuel Gandy